Perspectives from those who live it every day.
In the next podcast from Johns Hopkins Kimmel Cancer Center Director Dr Bill Nelson, he talks with Dr Trinity Bivalacqua, the Director of Urologic Oncology… Read More »Cancer Matters with Dr. Bill Nelson – Treatment Options For Bladder Cancer
Dr Bill Nelson talks with Dr David McConkey, Director of the Greenberg Bladder Cancer Institute at Johns Hopkins, about the renewed interest in bladder cancer… Read More »Cancer Matters with Dr. Bill Nelson – New Paradigms in the Treatment of Bladder Cancer
On a weekend before a business trip, Ken Brothers noticed some blood in his urine. He wondered if it was related his recent loss of… Read More »The State of the Bladder Cancer Battle
The Johns Hopkins Greenberg Bladder Cancer Institute recently announced a joint effort with the Bladder Cancer Advocacy Network (BCAN) to fund up to two awards totaling… Read More »What’s next for bladder cancer research?
With recent FDA approvals of immunotherapy drugs for kidney and bladder cancer, patients now have more options to consider among their treatments. The 2016 ASCO… Read More »ASCO annual meeting features clinical trial results of immunotherapy for bladder and kidney cancer
A new immunotherapy drug -- the first in its class -- was approved by the Food and Drug Administration last week for bladder cancer. We… Read More »New immunotherapy drug approved to treat bladder cancer
***This blog is the third in a three-part series on bladder cancer. Read parts one and two. The Johns Hopkins Greenberg Bladder Cancer Institute held… Read More »Symposium Spotlight on Bladder Cancer
***This blog is the second in a three-part series on bladder cancer. Read part one. Trinity Bivalacqua, M.D., Ph.D., director of urologic oncology in the… Read More »Bivalacqua Directs Bladder Cancer Advocacy Network Meeting Panel
***This blog is the first in a three-part series on bladder cancer. For too long, bladder cancer has been called the invisible cancer. But a… Read More »Bladder Cancer: No Longer Invisible